Reports Archive - Labiotech.eu https://www.labiotech.eu/reports/ The European Biotech News Website Tue, 16 May 2023 10:22:50 +0000 en-US hourly 1 https://wordpress.org/?v=6.1.1 https://www.labiotech.eu/wp-content/uploads/2020/04/cropped-favicon-32x32.png Reports Archive - Labiotech.eu https://www.labiotech.eu/reports/ 32 32 Outsourcing in life science R&D today https://www.labiotech.eu/report/outsourcing-in-life-science-research-development/ Tue, 16 May 2023 10:22:50 +0000 https://www.labiotech.eu/?post_type=lab_report&p=116550 Learn how online platforms facilitate outsourcing in life science R&D Dive into our report and… More about this report: Over the last two decades, outsourcing has become an integral part of life science R&D. Today, life science companies routinely outsource significant portions of their R&D activities to external suppliers – including complex, specialized services that […]

The post Outsourcing in life science R&D today appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> New frontiers in vaccinology https://www.labiotech.eu/report/advances-in-vaccine-technology-2022/ Tue, 14 Feb 2023 16:36:24 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112095 Learn about the latest advances in vaccine technology Dive into our report and… More about this report: The rapid approval and deployment of mRNA vaccines in response to the COVID-19 pandemic catapulted nucleic acid vaccines to the world stage, with soaring scientific and public recognition of mRNA vaccines and mRNA as a promising therapeutic. In […]

The post New frontiers in vaccinology appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Cell Therapy Industry Report 2022 https://www.labiotech.eu/report/cell-therapy-industry-report-2022-2/ Wed, 15 Feb 2023 11:59:59 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112109 Learn about the global cell therapy industry in 2022 Dive into our report and… More about this report: By 2028, the value of the global cell therapy market is projected to surpass $45B, up from less than $20B in 2020. Some industry insiders even anticipate that cell and gene therapies will overtake conventional drug therapies […]

The post Cell Therapy Industry Report 2022 appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> The European Biotech Startup Ecosystem https://www.labiotech.eu/report/the-european-biotech-startup-ecosystem/ Wed, 15 Feb 2023 12:34:23 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112118 Learn more about the current biotech landscape in Europe Dive into our report and… More about this report: The European biotech landscape has undergone great changes in the last decade. With an abundance of accessible talent, leading academic institutions, incubators, and powerful investors, Europe is now seen as a stronghold for fundamental research and innovation […]

The post The European Biotech Startup Ecosystem appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Gene Therapy Industry Report 2021 https://www.labiotech.eu/report/gene-therapy-industry-report-2021/ Wed, 15 Feb 2023 12:47:14 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112123 Learn more about the growing gene therapy market Dive into our report and discover… More about this report: By 2019, the global gene therapy market was on a trajectory to skyrocket, with a market value of €2.74B. But then the Covid-19 pandemic swept across the globe. The gene therapy market took a big hit, as […]

The post Gene Therapy Industry Report 2021 appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> European Biotech Industry Report 2021 https://www.labiotech.eu/report/european-biotech-industry-report-2021/ Wed, 15 Feb 2023 15:22:39 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112130 Learn about the biotech industry in Europe Dive into our report and… More about this report: The year 2020 was a rollercoaster ride for the life sciences. This report discusses how the Covid-19 pandemic has impacted Europe’s biotech and pharma industries and covers notable market trends, investments, fundraisings, mergers and acquisitions, and collaborations that occurred […]

The post European Biotech Industry Report 2021 appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> The Genome Editing Toolbox: ZFNs, TALENs, and CRISPR in Biomedicine https://www.labiotech.eu/report/the-genome-editing-toolbox-zfns-talens-and-crispr-in-biomedicine/ Wed, 15 Feb 2023 15:34:02 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112134 Learn more about current genome editing tools Dive into our report and… More about this report: While genome editing tools have been around for decades, most of the credit for this meteoric rise goes to CRISPR-Cas9. Its potential to change the lives of millions of patients around the world has piqued the interest of small […]

The post The Genome Editing Toolbox: ZFNs, TALENs, and CRISPR in Biomedicine appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Navigating the Immunotherapy Maze https://www.labiotech.eu/report/navigating-the-immunotherapy-maze/ Wed, 15 Feb 2023 15:56:34 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112141 Learn more about the immunotherapy market Dive into our report and… More about this report: The immunotherapy sector is booming and in 2020, the global immunotherapy market was valued at €139B. Within the next five years, the market will grow another €10B to reach €149.3B. This report takes a closer look at immunotherapies and discover […]

The post Navigating the Immunotherapy Maze appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Guidelines for Early-Stage Biotechs https://www.labiotech.eu/report/guidelines-for-early-stage-biotechs/ Thu, 16 Feb 2023 09:24:55 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112148 Learn to navigate the early stages of drug development Dive into our report and learn how to… More about this report: The global biotech industry is booming, and by 2025 it will reach an estimated market worth of $729B. But while great innovation is driven by emerging biotechs, these companies often lack resources, infrastructure, and […]

The post Guidelines for Early-Stage Biotechs appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Current and Emerging Approaches for Autoimmune Diseases https://www.labiotech.eu/report/current-and-emerging-approaches-for-autoimmune-diseases/ Wed, 15 Feb 2023 16:09:45 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112145 Learn more about new treatments for autoimmune diseases Dive into our report and… More about this report: Nearly 4% of the world’s population is affected by one or more of 80 autoimmune diseases identified to date. By 2025, the autoimmune disease treatment market is estimated to reach a staggering $7.95B in value. This guide takes […]

The post Current and Emerging Approaches for Autoimmune Diseases appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> A Guide to Current Therapies in Immuno-Oncology https://www.labiotech.eu/report/a-guide-to-current-therapies-in-immuno-oncology/ Thu, 16 Feb 2023 10:23:17 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112158 Learn more about therapeutic approaches and the exciting future of immuno-oncology. Growing at a compound annual growth rate of 9,6%, the global immuno-oncology market is expected to reach a staggering value of $127B by 2026. What breakthroughs have led to these incredible developments and where are we going? From a rich history to a growing […]

The post A Guide to Current Therapies in Immuno-Oncology appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> The Human Kinome: A Study of Protein Kinases https://www.labiotech.eu/report/the-human-kinome-a-study-of-protein-kinases/ Thu, 16 Feb 2023 10:45:13 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112165 Learn about the the use of kinases as therapeutics Dysregulation or mutations in kinases can result in numerous diseases. In fact, over 85% of the human kinome is involved in at least one disease or disorder, including cancer, cardiovascular disease, and neurological disorders. Of over 500 kinases, only 80 have been targeted for the treatment […]

The post The Human Kinome: A Study of Protein Kinases appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Peptides and Nucleic Acid Therapeutics: Dancing a Triumphant Tango https://www.labiotech.eu/report/peptides-and-nucleic-acid-therapeutics-dancing-a-triumphant-tango/ Thu, 16 Feb 2023 11:20:12 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112168 Learn about the clinical potential of nucleic acid therapeutics Increasing advances in genetics and bioengineering technologies have made gene therapy more accessible than ever before. The field of nucleic acid therapeutics, which is based on DNA, RNA, or closely related chemical compounds, is seen as promising for the treatment of genetic disorders and other diseases, […]

The post Peptides and Nucleic Acid Therapeutics: Dancing a Triumphant Tango appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Antibodies Through the Magnifying Glass: Their Past, Present and Future https://www.labiotech.eu/report/antibodies-through-the-magnifying-glass-their-past-present-and-future/ Thu, 16 Feb 2023 11:28:22 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112171 Learn more about the history of antibody discovery, the present use of antibodies as therapies and the future of antibody research. One hundred thirty billion dollars – that’s the estimated worth of antibodies on the global market today. Compared to ten years ago, when global sales of antibodies reached $39B, this is an exciting leap. […]

The post Antibodies Through the Magnifying Glass: Their Past, Present and Future appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> Beyond the Gut: An Atlas of the Human Microbiome https://www.labiotech.eu/report/gut-microbiomes-for-drug-discovery-and-development/ Thu, 16 Feb 2023 11:47:36 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112174 Learn more about how the gust microbiomes can be used for drug discovery and development  Our entire body is made up of trillions of microorganisms – not only cells, as you may have believed. They even outnumber your cells ten to one. We call this flourishing flora of microorganisms the human microbiome.  The microorganisms in our […]

The post Beyond the Gut: An Atlas of the Human Microbiome appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> A Toolkit for Emerging Biotechs: Practical Advice For Clinical Development https://www.labiotech.eu/report/a-toolkit-for-emerging-biotechs-practical-advice-for-clinical-development/ Thu, 16 Feb 2023 12:04:12 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112180 Learn more about the different challenges emerging biotechs face in the industry Emerging biotechs are taking control of drug development pipelines. But as they become increasingly important players in the industry, leading innovation in the drug discovery and development space, competition grows too. In collaboration with: More about this report: In this report, we discuss […]

The post A Toolkit for Emerging Biotechs: Practical Advice For Clinical Development appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]> The Digital Transformation of the Research Lab: From Pen & Paper to Voice Recognition & AI https://www.labiotech.eu/report/laboratory-digitalization-from-pen-paper-to-voice-recognition-ai/ Thu, 16 Feb 2023 12:26:23 +0000 https://www.labiotech.eu/?post_type=lab_report&p=112186 Learn about the benefits and future of laboratory digitalization In the US alone, more than $28B are lost annually on research that cannot be reproduced. Why? One reason is that many researchers still work with paper. But digitization, the process of turning paper-based information into a digital format, can make research more reproducible and efficient. […]

The post The Digital Transformation of the Research Lab: From Pen & Paper to Voice Recognition & AI appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

]]>